258
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta

ORCID Icon, , ORCID Icon &
Pages 3192-3199 | Received 05 Sep 2019, Accepted 09 Oct 2019, Published online: 24 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sibel Ozler, Efser Oztas, Aysegul Kebapcilar & Ali Turhan Caglar. (2022) The role of thyroid-stimulating hormone and thyroglobulin antibody in abnormally invasive placenta. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 5108-5116.
Read now

Articles from other publishers (2)

Nuriban Valero-Pacheco, Eric K. Tang, Noura Massri, Rachel Loia, Anat Chemerinski, Tracy Wu, Salma Begum, Darine W. El-Naccache, William C. Gause, Ripla Arora, Nataki C. Douglas & Aimee M. Beaulieu. (2022) Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice. Proceedings of the National Academy of Sciences 119:35.
Crossref
Jessica E. Miller, Madhuri Koti & Chandrakant Tayade. (2022) IL-33–ILC2 axis in the female reproductive tract. Trends in Molecular Medicine 28:7, pages 569-582.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.